POWERED BY MOMENTUM MEDIA
IOOF completes NAB trustee business acquisition
IOOF has completed the acquisition of National Australia Trustees Limited (NATL) by its trustee business, Australian Executor Trustees Limited (AET).
IOOF entered into an agreement with National Australia Bank (NAB) in June to purchase NATL, including the NATL Personal Trustee business and select trustee arrangements in the NATL Corporate Trustee business.
IOOF managing director, Christopher Kelaher, said: “We are excited by the benefits the acquisition will deliver to the advisers and clients of both AET and NATL”.
“NATL is a strong strategic fit for AET, with AET now becoming one of the largest providers of compensation trust services in Australia,” he said.
He added the increased scale would provide NATL clients with access to a wider range of specialist estate and trustee services, and said it demonstrated the firm’s commitment to providing advisers and clients with professional estate and trustee services as part of wealth management.
NATL customers would be contacted and advised of the change in ownership, IOOF said.
Recommended for you
New research has shown that investing in alternative assets and using active management has, to this point, delivered strong results for Australian super funds.
Australia’s $4 trillion superannuation industry is fundamentally reshaping the nation’s external accounts, setting the stage for a more sustainable current account surplus despite weaker commodity markets.
Rest has expanded its portfolio of renewable energy infrastructure by supporting a Victorian solar farm and battery project.
Economic growth was weaker than expected, once again highlighting an economy largely sustained by population growth and government spending.
TOP PERFORMING FUNDS
ACS FIXED INT - AUSTRALIA/GLOBAL BOND
Fund name
3y(%)pa
1
DomaCom DFS Mortgage
93.34 3 y p.a(%)
2
Global X GlobalX FANG+ ETF
37.15 3 y p.a(%)
3
GAM LSA Private Shares AU I
33.96 3 y p.a(%)
4
Fidante Credit Suisse Global Private Equity
29.68 3 y p.a(%)
5
Plato Global Alpha A
28.73 3 y p.a(%)
